ReviewJournal of asthma and allergy2018

Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.

Farnaz Tabatabaian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.